Throughout his time performing neuro-oncology research at the National Institutes of Health (NIH), Stephen has developed a passion for designing immune-based therapies for the treatment of brain tumors. This research has allowed him to recognize there is an immense challenge in ensuring patients throughout the world have equitable access to these promising therapies. He joined DGNN to be involved in more than patient care and making the medicines of tomorrow.  He wants to contribute to projects that are aimed at sharing promising innovations in medicine with the most medically underserved populations in the world.